IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Frazier Management LLC

Q2 2019 Holdings

Filed 2019-08-14 | 18 holdings | $25.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Collegium Pharmaceutical Inc(COLL)COM19459J104$24.8M1,887,33298.5%
Anaptysbio Inc(ANAB)COM032724106$130.7K2,316,4470.5%
Iovance Biotherapeutics Inc(IOVA)COM462260100$53.7K2,188,3310.2%
Krystal Biotech Inc(KRYS)COM501147102$36.0K895,0000.1%
Gritstone Oncology Inc(2JQ)COM39868T105$23.0K2,061,7580.1%
Translate BIO IncCOM89374L104$21.3K1,682,7890.1%
Millendo Therapeutics IncCOM60040X103$16.1K1,396,6150.1%
Allena Pharmaceuticals Inc(ALNAEUR)COM018119107$13.6K3,330,3730.1%
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$10.8K2,571,4500.0%
Aptinyx IncCOM03836N103$10.7K3,190,0790.0%
Iterum Therapeutics PLCSHSG6333L101$10.6K1,538,3160.0%
Nabriva Therapeutics PLCSHSG63637105$10.3K4,256,5260.0%
Entasis Therapeutics Hldgs ICOM293614103$8.7K1,349,9530.0%
Synlogic IncCOM87166L100$7.9K865,4070.0%
Sierra Oncology IncCOM82640U107$4.5K8,112,1210.0%
Kezar Life Sciences IncCOM49372L100$3.6K467,7430.0%
Cidara Therapeutics IncCOM171757107$2.2K1,312,2580.0%
Bellicum Pharmaceuticals IncCOM079481107$1.8K1,051,4410.0%